詞庫查詢
查詢 Elsevier TF-IDF 關鍵詞（16,935 詞）與 THU 中文擴充詞庫。想知道自己的研究會命中哪些規則？先查這裡。
Elsevier TF-IDF 詞 16,935 筆
| SDG | 目標 | 詞 | 集合內文獻 | Scopus 文獻 | 佔比 | TF-IDF |
|---|---|---|---|---|---|---|
| 3 | 良好健康與福祉 | anthracycline-based |
2,111 | 2,215 | 95% | 19.31 |
| 3 | 良好健康與福祉 | risk of ischemic stroke |
2,549 | 2,682 | 95% | 19.31 |
| 3 | 良好健康與福祉 | sentinel node biopsy |
3,291 | 3,437 | 96% | 19.31 |
| 3 | 良好健康與福祉 | metastatic rcc |
2,212 | 2,325 | 95% | 19.31 |
| 3 | 良好健康與福祉 | interferon and ribavirin |
2,763 | 2,905 | 95% | 19.31 |
| 3 | 良好健康與福祉 | tumor-node-metastasis |
2,416 | 2,543 | 95% | 19.31 |
| 3 | 良好健康與福祉 | adjuvant chemoradiation |
2,876 | 3,021 | 95% | 19.31 |
| 3 | 良好健康與福祉 | crc risk |
2,180 | 2,291 | 95% | 19.31 |
| 3 | 良好健康與福祉 | sln biopsy |
1,478 | 1,513 | 98% | 19.31 |
| 3 | 良好健康與福祉 | national comprehensive cancer network |
3,885 | 4,013 | 97% | 19.31 |
| 3 | 良好健康與福祉 | concurrent chemoradiation |
2,124 | 2,231 | 95% | 19.31 |
| 3 | 良好健康與福祉 | pharyngeal squamous cell carcinoma |
3,352 | 3,499 | 96% | 19.31 |
| 3 | 良好健康與福祉 | neoadjuvant chemotherapy (nac) |
3,010 | 3,158 | 95% | 19.31 |
| 3 | 良好健康與福祉 | epidermal growth factor receptor (egfr) mutation |
2,141 | 2,250 | 95% | 19.31 |
| 3 | 良好健康與福祉 | small cell lung cancer |
1,873 | 1,957 | 96% | 19.31 |
| 3 | 良好健康與福祉 | sentinel lymph node (sln) |
3,137 | 3,287 | 95% | 19.31 |
| 3 | 良好健康與福祉 | metastatic castration-resistant prostate cancer |
3,257 | 3,407 | 96% | 19.31 |
| 3 | 良好健康與福祉 | end-stage kidney disease (eskd) |
1,595 | 1,647 | 97% | 19.31 |
| 3 | 良好健康與福祉 | acute ischemic stroke patients |
2,769 | 2,914 | 95% | 19.31 |
| 3 | 良好健康與福祉 | hiv/sti |
1,518 | 1,560 | 97% | 19.31 |
| 3 | 良好健康與福祉 | cancer cell apoptosis |
2,422 | 2,552 | 95% | 19.31 |
| 3 | 良好健康與福祉 | chronic thromboembolic pulmonary hypertension |
2,552 | 2,689 | 95% | 19.31 |
| 3 | 良好健康與福祉 | prostate cancer (pc) |
3,327 | 3,477 | 96% | 19.31 |
| 3 | 良好健康與福祉 | atherosclerosis cardiovascular disease |
2,750 | 2,895 | 95% | 19.31 |
| 3 | 良好健康與福祉 | autoimmune hepatitis (aih) |
2,337 | 2,462 | 95% | 19.31 |
| 3 | 良好健康與福祉 | egfr tyrosine kinase inhibitors |
1,929 | 2,020 | 95% | 19.31 |
| 3 | 良好健康與福祉 | metastatic setting |
2,038 | 2,140 | 95% | 19.31 |
| 3 | 良好健康與福祉 | advanced hepatocellular carcinoma (hcc) |
1,785 | 1,861 | 96% | 19.31 |
| 3 | 良好健康與福祉 | hiv prevention intervention |
1,827 | 1,908 | 96% | 19.31 |
| 3 | 良好健康與福祉 | prevention of mother-to-child transmission |
2,001 | 2,100 | 95% | 19.31 |
| 3 | 良好健康與福祉 | prostate cancer treatment |
2,984 | 3,136 | 95% | 19.31 |
| 3 | 良好健康與福祉 | primary effusion lymphoma |
1,476 | 1,514 | 97% | 19.31 |
| 3 | 良好健康與福祉 | hiv-infected adults |
2,746 | 2,894 | 95% | 19.31 |
| 3 | 良好健康與福祉 | obesity type |
2,341 | 2,469 | 95% | 19.31 |
| 3 | 良好健康與福祉 | chronic hepatitis c virus (hcv) |
3,406 | 3,559 | 96% | 19.31 |
| 3 | 良好健康與福祉 | primary effusion |
1,502 | 1,544 | 97% | 19.31 |
| 3 | 良好健康與福祉 | crc screening |
3,222 | 3,378 | 95% | 19.31 |
| 3 | 良好健康與福祉 | locally advanced rectal cancer |
3,471 | 3,624 | 96% | 19.31 |
| 3 | 良好健康與福祉 | large vessel occlusion |
2,952 | 3,107 | 95% | 19.31 |
| 3 | 良好健康與福祉 | papillary thyroid cancer (ptc) |
2,025 | 2,129 | 95% | 19.31 |
| 3 | 良好健康與福祉 | latent tuberculosis infection |
3,195 | 3,352 | 95% | 19.31 |
| 3 | 良好健康與福祉 | chronic thromboembolic pulmonary |
2,570 | 2,713 | 95% | 19.31 |
| 3 | 良好健康與福祉 | hbv dna level |
2,411 | 2,546 | 95% | 19.31 |
| 3 | 良好健康與福祉 | metastatic castration-resistant |
3,428 | 3,584 | 96% | 19.31 |
| 3 | 良好健康與福祉 | diabetes medication |
2,091 | 2,202 | 95% | 19.31 |
| 3 | 良好健康與福祉 | nmibc |
2,289 | 2,416 | 95% | 19.31 |
| 3 | 良好健康與福祉 | ckd stages |
2,194 | 2,314 | 95% | 19.31 |
| 3 | 良好健康與福祉 | cancer stem cell (csc) |
1,936 | 2,033 | 95% | 19.31 |
| 3 | 良好健康與福祉 | substance use disorders (suds) |
1,680 | 1,748 | 96% | 19.31 |
| 3 | 良好健康與福祉 | neuroblastoma sh-sy5y cell |
1,829 | 1,915 | 96% | 19.31 |